National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies Date
Topics
- Cancer (2)
- Cancer: Breast Cancer (2)
- (-) Cancer: Ovarian Cancer (4)
- Case Study (1)
- Evidence-Based Practice (1)
- Family Health and History (1)
- Genetics (2)
- Guidelines (1)
- Prevention (1)
- Quality of Care (1)
- Racial and Ethnic Minorities (1)
- Screening (4)
- Social Determinants of Health (1)
- U.S. Preventive Services Task Force (USPSTF) (2)
- Women (2)
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 4 of 4 Research Studies DisplayedFan T, Uptegraft C
AHRQ Author: Fan T
Screening for ovarian cancer.
This case study addresses the U.S. Preventive Health Service Task Force recommendations and offers a scenario, questions, and answers related to screening for ovarian cancer.
AHRQ-authored.
Citation: Fan T, Uptegraft C .
Screening for ovarian cancer.
Am Fam Physician 2018 Jun 15;97(12):813-14..
Keywords: Cancer: Ovarian Cancer, Case Study, Prevention, Screening, U.S. Preventive Services Task Force (USPSTF)
Childers KK, Maggard-Gibbons M, Macinko J
National distribution of cancer genetic testing in the United States: evidence for a gender disparity in hereditary breast and ovarian cancer.
Identifying mutation carriers is critical for treatment decisions, cancer prevention, and early detection. This study analyzed the 2015 US National Health Interview Survey (NHIS), a cross-sectional in-person interview gathering self-reported health data for the US population. The study found that while cancer genetic testing seems to reach a broad geographic and sociodemographic population in the national survey, there remain underrepresented groups, including Hispanics, the uninsured, noncitizens, and those with less education.
AHRQ-funded; HS025079.
Citation: Childers KK, Maggard-Gibbons M, Macinko J .
National distribution of cancer genetic testing in the United States: evidence for a gender disparity in hereditary breast and ovarian cancer.
JAMA Oncol 2018 Jun;4(6):876-79. doi: 10.1001/jamaoncol.2018.0340..
Keywords: Cancer, Cancer: Breast Cancer, Cancer: Ovarian Cancer, Genetics, Racial and Ethnic Minorities, Screening, Social Determinants of Health, Women
Henderson JT, Webber EM, Sawaya GF
Screening for ovarian cancer: Updated evidence report and systematic review for the US Preventive Services Task Force.
The researchers systematically reviewed evidence on benefits and harms of ovarian cancer screening among average-risk women to inform the United States Preventive Services Task Force. They concluded that, in randomized trials conducted among average-risk, asymptomatic women, ovarian cancer mortality did not significantly differ between screened women and those with no screening or in usual care.
AHRQ-funded; 290201500007I.
Citation: Henderson JT, Webber EM, Sawaya GF .
Screening for ovarian cancer: Updated evidence report and systematic review for the US Preventive Services Task Force.
JAMA 2018 Feb 13;319(6):595-606. doi: 10.1001/jama.2017.21421.
.
.
Keywords: Evidence-Based Practice, Guidelines, Cancer: Ovarian Cancer, Screening, U.S. Preventive Services Task Force (USPSTF)
Childers CP, Childers KK, Maggard-Gibbons M
National estimates of genetic testing in women with a history of breast or ovarian cancer.
In the United States, 3.8 million women have a history of breast (BC) or ovarian cancer (OC). Up to 15 percent of cases are attributable to heritable mutations, which, if identified, provide critical knowledge for treatment and preventive care. This study found that fewer than one in five individuals with a history of BC or OC meeting select National Cancer Comprehensive Network criteria have undergone genetic testing.
AHRQ-funded; HS025079.
Citation: Childers CP, Childers KK, Maggard-Gibbons M .
National estimates of genetic testing in women with a history of breast or ovarian cancer.
J Clin Oncol 2017 Dec 1;35(34):3800-06. doi: 10.1200/jco.2017.73.6314.
.
.
Keywords: Cancer, Cancer: Breast Cancer, Cancer: Ovarian Cancer, Family Health and History, Genetics, Quality of Care, Screening, Women